The Foundation supports research that can lead to the creation of better Parkinson's treatments. Here you can search previously awarded grants by keyword, program name, researcher name, institution or organization name and/or year.
FUNDED GRANTS ( 8)
Therapeutic Pipeline Program, 2015
There is a critical need for treatments that address depression and barriers to care among the approximately 5 million people living with Parkinson's disease (PD) worldwide. The purpose of this research is to test a new treatment (Telephone-Administered Cognitive Behavioral Therapy or T-CBT) for depression in PD. The treatment does not involve medication but teac...
Researchers: Roseanne D. Dobkin, PhD
Improved Biomarkers and Clinical Outcome Measures, 2015
Current methods to evaluate motor impairments in Parkinson's disease rely on subjective examinations. Our team seeks to develop an objective assessment of motor deficits by monitoring natural interactions with a keyboard (on a computer or smart device). This approach provides a window to how the brain behaves during typical daily use of these devices (e.g. writin...
Researchers: Martha L. Gray, PhD
Research Grant, 2013
Ubiquitous, Inexpensive Non-invasive Technologies for Objective Detection and Monitoring of Parkinson's Symptoms
For doctors to diagnose and treat Parkinson's, they need reliable tests. Unfortunately, testing the symptoms of Parkinson's at a specialist's office/clinic is expensive and time-consuming. We have found that voice recordings collected in the clinic contain enough information to detect Parkinson's, but we want to test the same capability over the phone, or using smartphones, suc...
Researchers: Max A. Little, PhD
MJFF Research Grant, 2008
Wearable Sensors and a Web-Based Application to Monitor Patients with Parkinson's Disease in the Home Environment
Critical research roadblocks hinder our ability to identify genetic and environmental causes of Parkinson’s disease and to develop novel, transformative therapies for Parkinson’s disease patients. Traditional clinical trials require multiple patient visits to a limited number of skilled clinical sites. These visits can be time and distance prohibitive for patients, and requir...
Developing and Validating Web-Based Clinical Assessments for, 2008
Problems with visual perception (such as blurry vision or judging distances) are common in people with Parkinson’s disease. Visuospatial impairments are associated with some of the most serious motor symptoms (freezing and falling) and can affect performance of critical every day activities such as driving and reading. The purpose of this project is to create an easy-to-use o...
Researchers: Melissa Amick, PhD